Search results
Results from the WOW.Com Content Network
200 West Street is the global headquarters of the Goldman Sachs investment banking firm in the Battery Park City neighborhood of Manhattan in New York City. The building is a 749-foot-tall (228 m), 44-story building located on West Street, between Vesey and Murray Streets in Lower Manhattan. It is adjacent to Brookfield Place and the Conrad ...
In September 2011, Goldman Sachs announced that it was shutting down Global Alpha Fund LP, its largest hedge fund, which had been housed under Goldman Sachs Asset Management (GSAM). [ 83 ] [ 84 ] Global Alpha, which was created in the mid-1990s with $10 million, [ 85 ] was once "one of the biggest and best performing hedge funds in the world ...
Jeffrey Currie. Jeff Currie is an economist and currently Chief Strategy Officer of Energy Pathways at The Carlyle Group. He is the former Global Head of Commodities Research in the Global Investment Research Division at Goldman Sachs. He rose to prominence during the 2000s by forecasting the commodity super-cycle and oil spiking above $100 a ...
September 3, 2024 at 6:26 PM. Investors should "go for gold" as the precious metal's stellar run isn't over, Goldman Sachs analysts said in a research note. On Tuesday, gold futures (GC=F) hovered ...
Jan Hatzius. Jan Hatzius (born December 17, 1968) is the chief economist of investment bank Goldman Sachs. Notable for his bearish forecasts prior to the Financial crisis of 2007–2008, he is a two-time winner of the Lawrence R. Klein Award for the most accurate US economic forecast over the prior four years. [1][2] He has also won a number of ...
Steven Strongin (born July 30, 1958) is a Senior Advisor at Goldman Sachs. [ 1] Previously, he was the head of Global Investment Research and chair of the Global Markets Institute at Goldman Sachs. [ 2] He was a member of the Management Committee, Firmwide Client and Business Standards Committee and was also co-chair of the Firmwide Technology ...
Goldman Sachs analysts attempted to address a touchy subject for biotech companies, especially those involved in the pioneering "gene therapy" treatment: cures could be bad for business in the ...
Goldman Sachs has historically invested capital in a variety of businesses alongside its investment banking clients. [2] In the early and mid-1980s, Goldman was a slow entrant into the financing of leveraged buyouts and junk bonds and preferred to focus on its traditional mergers and acquisitions advisory business. Beginning in 1983, however ...